Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
LEADS BIOLABS-B
LEADS BIOLABS-B (09887.HK): Chairman Plans HKD 20M H-Share Purchase
Tags:
LEADS BIOLABS-B
09887.HK
Share Acquisition
2026-11-20
LEADS BIOLABS-B (09887.HK): Presents LBL-024 Data at Jefferies
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Data
2026-11-20
LEADS BIOLABS-B (09887.HK): LBL-047 completes first SLE patient dosing in Phase I Part B
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Progress
2026-10-30
LEADS BIOLABS-B (09887.HK): LBL-024 data presented at ESMO 2026, 3L EP-NEC median OS 8.7 months
Tags:
LEADS BIOLABS-B
09887.HK
overseas
2026-10-26
LEADS BIOLABS-B (09887.HK): Updated LBL-034 Data in RRMM Presented at ESMO
Tags:
NewTimeSpace
LEADS BIOLABS-B
09887.HK
2026-10-25
LEADS BIOLABS-B (09887.HK): Six Abstracts on Weilixin and LBL-034 Published at ESMO 2026; Three Chosen for Oral Presentations
Tags:
NewTimeSpace
LEADS BIOLABS-B
09887.HK
2026-10-19
LEADS BIOLABS-B (09887.HK): First Patient Enrolled in Phase Ib/II Study of Vescuterlimab in mCRC
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Trial
2026-10-16
LEADS BIOLABS-B (09887.HK): Vilasumu Wins FDA Fast Track for Biliary Tract Cancer
Tags:
LEADS BIOLABS-B
09887.HK
overseas
2026-10-12
LEADS BIOLABS-B (09887.HK): Pivotal EP-NEC Study Selected as ESMO Late-Breaking Abstract
Tags:
NewTimeSpace
LEADS BIOLABS-B
09887.HK
2026-09-21
LEADS BIOLABS-B (09887.HK): Updated Phase II Data of Vilxin® Combined with Chemotherapy as First-Line Treatment for NSCLC Presented in Oral Presentation at WCLC 2026
Tags:
LEADS BIOLABS-B
09887.HK
R&D Progress
2026-09-14
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Tags:
LEADS BIOLABS-B
09887.HK
R&D Progress
2026-08-21
LEADS BIOLABS-B (09887.HK): Phase II study abstract of Vimx (opasumivimab) as first-line NSCLC therapy published on WCLC website
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Progress
2026-08-20
LEADS BIOLABS-B (09887.HK): Oblenio exercises option to retain license for LBL-051, Company to receive USD 10 million
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Progress
2026-08-20
Nanjing Leads Biolabs-B (09887.HK): LBL-024 (WeilixinTM) Phase II Study for First-Line HCC Treatment Enters Expansion Stage
Tags:
LEADS BIOLABS-B
09887.HK
2026-08-06
LEADS BIOLABS-B(09887.HK): Partner Oblenio Bio Completes First‑in‑Human Phase Ia First‑Patient Dosing of LBL‑051 for Refractory Autoimmune Diseases
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Trial
2026-08-04
LEADS BIOLABS-B (09887.HK): Six Research Abstracts Accepted for ESMO Congress 2026, Including Two Proffered Paper Presentations and LBA Eligibility
Tags:
LEADS BIOLABS-B
09887.HK
ESMO
2026-07-13
LEADS BIOLABS-B (09887.HK): VELIXIN™ Granted Priority Review by NMPA for Advanced Extrapulmonary Neuroendocrine Carcinoma
Tags:
LEADS BIOLABS-B
09887.HK
New Drug Application
2026-07-10
Leads Biolabs-B (09887.HK) Partner Oblenio Closes Oversubscribed $62M Series B Led by Pfizer Ventures
Tags:
LEADS BIOLABS-B
09887.HK
2026-06-25
Leads Biolabs-B (09887.HK): Core Bispecific Antibody Initiates Phase Ib/II Trial for Triple-Negative Breast Cancer
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Trial
2026-02-10
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App